(Q36701442)

15 August 2017

Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer (English)

1 reference

15 August 2017

0 references

John J Coen

1

1 reference

15 August 2017

Anthony L Zietman

series ordinal

2

1 reference

15 August 2017

Donald S Kaufman

series ordinal

3

1 reference

15 August 2017

William U Shipley

series ordinal

4

1 reference

15 August 2017

language of work or name

1 reference

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

25

1 reference

15 August 2017

76-84

1 reference

15 August 2017

1

1 reference

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

An organ-preserving approach to muscle-invading transitional cell cancer of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Bladder cancer.Superiority of preoperative irradiation and cystectomy in clinical stages B2 and C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. A survey by a self-administered questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Cystectomy for bladder cancer: a contemporary series

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Unconventional fractionation for palliative radiotherapy of urinary bladder cancer. A retrospective review of 94 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

A randomized trial of hypofractionated schedules of palliative radiotherapy in the management of bladder carcinoma: results of medical research council trial BA09.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Radiotherapeutic management of osseous metastases: a survey of current patterns of care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Randomized prospective clinical study of small, large and twice-a-day fraction radiotherapy for painful bone metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

Painful bone metastasis: efficacy of radiotherapy assessed by the patients: a randomized trial comparing 4 Gy X 6 versus 10 Gy X 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2006.05.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2006.05.012

1 reference

15 August 2017

1 reference